相关实验视频

Updated: Jun 24, 2025

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

个案个案全基因组分析识别了乳腺癌风险的亚型信息变体

Xiaohui Sun^1,2, Shiv P Verma¹, Guochong Jia³

¹Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.

Cancer research

|June 4, 2024

概括

这项研究发现了乳腺癌亚型的新遗传风险变异,特别是三阴性乳腺癌 (TNBC). 这些发现提高了对乳腺癌的理解.

科学领域:

遗传学是一个遗传学.
在瘤学瘤学.
流行病学流行病学

背景情况:

乳腺癌包括具有明显临床和生物特征的异质亚型.
了解亚型特定的遗传病因对于有针对性的预防和治疗策略至关重要.
以前的研究已经确定了一些乳腺癌易感点,但对亚型的具体见解仍然有限.

研究的目的:

用个案个案全基因组关联研究 (CC-GWAS) 方法阐明乳腺癌的亚型特定遗传病因.
确定与特定乳腺癌亚型相关的新型遗传位置,特别是三阴性乳腺癌 (TNBC).
开发和验证乳腺癌风险和生存率的亚型信息型多基因风险评分 (PRS).

主要方法:

在乳腺癌协会联盟的总结统计数据上应用了一种对对对案例全基因组关联研究 (CC-GWAS) 方法.
在五种乳腺癌亚型中进行了对对比.
进行精细映射以识别假设的功能变异和风险基因,并对特定SNP进行功能调查 (rs16867605).
通过使用CC-GWAS数据和外部队列,推导和验证亚型信息型多基因风险评分 (PRS).

主要成果:

确定了13个统计学意义上的基因位点和8个暗示性的基因位点,主要是从三阴性乳腺癌 (TNBC) 和光线A乳腺癌之间的比较中得出的.
确认了12个位点的变异的关联,其中包括两个全基因组显著的位点,在考虑到已知的易感性变异之后.
精细映射涉及TNBC的特定基因 (例如TNFSF10,NACAP1/GRHL2,LINC00536/TRPS1) 的精细映射.
证明高亚型信息性PRS与光线癌相比,TNBC的风险增加了多达两倍.
CC-GWAS PRS显示了独立于传统TNBC PRS的统计学意义,并与整体和疾病特异性存活率相关.

结论:

这项研究促进了对乳腺癌亚型特定遗传病因学的理解,特别是在TNBC.
发现亚型信息性遗传风险变异突显了乳腺癌的病因异质性.
这些发现可以加快治疗点的确定和针对乳腺癌的个性化预防/治疗策略.

更多相关视频

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

相关概念视频

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Comparing Copy Number Variations and SNPs

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...